HIGHLIGHTS
- who: Yun Wu et al. from the Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/ Panjiayuan Nanli, Chaoyang District, Beijing, China have published the paper: Prognostic Value of the Serum HER2 Extracellular Domain Level in Breast Cancer: A Systematic Review and Meta-Analysis, in the Journal: Cancers 2022, 4551 of 11/09/2022
- what: The authors aimed to evaluate the prognostic value of serum HER2 extracellular domain (sHER2 ECD) in breast cancer and to identify its correlation with the efficacy of different treatment regimens. The characteristicsThe of the studies are . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.